When it comes to Acute Myeloid Leukemia (AML), genetic testing (or biomarker testing) is essential in helping to determine the best treatment approach for YOU. In this INSIST! AML webinar, AML expert Dr. Naval Daver will review key decision-making factors, current AML treatments and emerging research.
Watch online on Tuesday, September 15 at 1 PM Eastern (10 AM PT, 12 PM CT) for a 30-minute virtual webinar.
The Insist! AML program is brought to you by the Patient Empowerment Network. It is made possible through support from AbbVie, Inc., Astellas Pharma Inc., Bristol Myers Squibb, Foundation Medicine, Jazz Pharmaceuticals, and generous donations from people like you.